Decreased CXCL7 levels can also be used to differentiate pediatric acute lymphoblastic leukemia (ALL) patients from healthy controls and pediatric acute myeloid leukemia (AML) patients (Shi et al., 2009). Here, PPBP is linked to acute myeloid leukemia.